Literature DB >> 9870522

Cyclophosphamide-induced chromosomal aberrations and associated congenital malformations in rats.

A K Saxena, G Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870522     DOI: 10.1007/s11626-998-0027-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  9 in total

1.  Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

Authors:  G E FOLEY; O M FRIEDMAN; B P DROLET
Journal:  Cancer Res       Date:  1961-01       Impact factor: 12.701

2.  Aneuploidy induced by cyclophosphamide in developing rat testes.

Authors:  A K Saxena; G Singh
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

3.  DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.

Authors:  S A Little; P E Mirkes
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

Review 4.  Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.

Authors:  G R Mohn; J Ellenberger
Journal:  Mutat Res       Date:  1976       Impact factor: 2.433

5.  Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.

Authors:  B Chen; D G Cyr; B F Hales
Journal:  Teratology       Date:  1994-07

6.  DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver. Comparison with bone marrow test after 'in vivo' treatment with cyclophosphamide.

Authors:  A M Rossi; M Romano; L Zaccaro; R Pulci; M Salmona
Journal:  Mutat Res       Date:  1987-04       Impact factor: 2.433

Review 7.  Cyclophosphamide teratogenesis: a review.

Authors:  P E Mirkes
Journal:  Teratog Carcinog Mutagen       Date:  1985

8.  Changes in the frequency of chromosome aberrations in the bone marrow of mice examined at various intervals after single-dose and continual exposures to cyclophosphamide.

Authors:  R J Srám; V S Zhurkov; J Nováková; I Kodýtková
Journal:  Folia Biol (Praha)       Date:  1981       Impact factor: 0.906

Review 9.  Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses.

Authors:  A R Ahmed; S M Hombal
Journal:  J Am Acad Dermatol       Date:  1984-12       Impact factor: 11.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.